Aprea Therapeutics
APRE
APRE
23 hedge funds and large institutions have $3.07M invested in Aprea Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EAM
26
Exome Asset Management
New York
| – | – | -28,972 | Closed |
|
27
JPMorgan Chase & Co
New York
| – | – | -10 | Closed |
|